Physician profile
Marvin L Erickson
NPI 1679569776
$2,715.36
in general payments reported to CMS, 2019-2025
34 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $62.35 · 2021: $318 · 2022: $430 · 2023: $438 · 2024: $797 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,584 · Travel and Lodging: $19.00 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,583.64 |
| Travel and Lodging | $19.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $372.03 | 2024 | |
| Astellas Pharma US INC | $315.52 | 2024-2025 | Veozah |
| Abbvie INC. | $243.18 | 2019-2022 | |
| Exeltis, USA INC. | $224.83 | 2020-2025 | Slynd |
| Daiichi Sankyo INC. | $191.77 | 2021-2022 | |
| Hologic Sales and Service, LLC | $163.43 | 2019-2025 | Acessa Provu System, Aptima, Novasure |
| Organon LLC | $139.67 | 2022-2024 | Nexplanon |
| Medtronic, INC. | $122.79 | 2021-2023 | Truclear |
| Coopersurgical, INC. | $97.51 | 2022-2025 | Paragard T 380a, Endosee |
| Baxter Healthcare | $89.94 | 2024-2025 | Perclot |
| Mayne Pharma Commercial LLC | $72.06 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $69.80 | 2022-2023 | Seglentis |
| Myovant Sciences INC. | $62.68 | 2022 | |
| Therapeuticsmd, INC. | $59.55 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $57.87 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $57.86 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Pfizer INC. | $43.24 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $42.15 | 2019 | |
| Evofem Biosciences, INC. | $30.25 | 2022 | |
| Ethicon US, LLC | $26.67 | 2019 | |
| Amag Pharmaceuticals, INC. | $25.42 | 2019 | |
| Becton, Dickinson and Company | $21.47 | 2025 | Bd Onclarity |
| Monaghan Medical Corporation | $19.43 | 2024 | Aerobika |
| Biogen, INC. | $18.24 | 2025 | Zurzuvae |
| Avion Pharmaceuticals | $18.18 | 2023 | Balcoltra |
| Minerva Surgical, INC | $16.62 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.38 | 2019 | |
| Dexcom, INC. | $15.65 | 2023 | Dexcom G6 Transmitter |
| Agile Therapeutics, INC. | $15.43 | 2021 | |
| Innovation Technologies INC | $14.80 | 2024 | Irrisept |
| Northgate Technologies, INC. | $14.25 | 2024 | Stimsite |
| Sumitomo Pharma America, INC. | $13.30 | 2023 | Myfembree |
| Abbott Laboratories | $12.42 | 2019 | |
| Lupin INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.